The present invention relates to mixtures or compositions comprising a chondroitin sulfate of plant origin or an analogue thereof (algae extract) and to the use thereof in the preventive or curative treatment of diseases and symptoms caused by gastric reflux in the gastroesophageal tract or in extra-oesophageal regions, and ulcers, lacerations and/or inflammations of the mucous membranes or the lining tissues of the various anatomical regions present in the tract from the stomach to the oral cavity, also including the upper respiratory tract.

The present invention relates to mixtures or compositions comprising a chondroitin sulfate of plant origin or an analogue thereof (algae extract) and to the use thereof in the preventive or curative treatment of diseases and symptoms caused by gastric reflux in the gastroesophageal tract or in extra-oesophageal regions, and ulcers, lacerations and/or inflammations of the mucous membranes or the lining tissues of the various anatomical regions present in the tract from the stomach to the oral cavity, also including the upper respiratory tract.

Provided is a hair growth composition comprising capsaicin, a vegetable oil, activated charcoal, aluminum sulfate, saw palmetto, and kelp. A method of preparing the above hair growth composition is additionally provided. Use of the above hair growth composition for the manufacture of a medicament for the treatment of hair loss is also provided. A method of treating a subject suffering from hair loss is further provided.

Provided is a hair growth composition comprising capsaicin, a vegetable oil, activated charcoal, aluminum sulfate, saw palmetto, and kelp. A method of preparing the above hair growth composition is additionally provided. Use of the above hair growth composition for the manufacture of a medicament for the treatment of hair loss is also provided. A method of treating a subject suffering from hair loss is further provided.

In some embodiments, soothing redness correction formulations are provided. In other embodiments, formulations to treat skin discoloration via a multi-modal approach are provided in some embodiments in which select ingredients work together to effectively brighten skin and treat hyperpigmentation. In yet other embodiments, certain formulations are renewal formulations adapted to treat the eye area to, for example, reduce laxity, puffiness, wrinkles and/or dark circles around the eye.

In some embodiments, soothing redness correction formulations are provided. In other embodiments, formulations to treat skin discoloration via a multi-modal approach are provided in some embodiments in which select ingredients work together to effectively brighten skin and treat hyperpigmentation. In yet other embodiments, certain formulations are renewal formulations adapted to treat the eye area to, for example, reduce laxity, puffiness, wrinkles and/or dark circles around the eye.

Formulations such as serums to treat skin discoloration via a multi-modal approach are provided in some embodiments. In several embodiments, the formulations are configured to allow select ingredients to work together to effectively brighten skin and treat hyperpigmentation. In several embodiments, the formulations comprise a first anti-melanin agent, such as a Bidens pilosa extract, a second anti-melanin agent, such as a Rheum rhaponticum extract, and an anti-inflammatory agent, such as a Vitamin E compound. In several embodiments, the formulation is provided as a topical formulation.

Formulations such as serums to treat skin discoloration via a multi-modal approach are provided in some embodiments. In several embodiments, the formulations are configured to allow select ingredients to work together to effectively brighten skin and treat hyperpigmentation. In several embodiments, the formulations comprise a first anti-melanin agent, such as a Bidens pilosa extract, a second anti-melanin agent, such as a Rheum rhaponticum extract, and an anti-inflammatory agent, such as a Vitamin E compound. In several embodiments, the formulation is provided as a topical formulation.

A composition includes (i) a sugar alcohol selected from sorbitol, xylitol, and mixtures thereof; (ii) water in an amount of from about 20% to about 60% by weight of the composition; and (iii) a gelling agent.

A composition includes (i) a sugar alcohol selected from sorbitol, xylitol, and mixtures thereof; (ii) water in an amount of from about 20% to about 60% by weight of the composition; and (iii) a gelling agent.